Cargando…
Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway
BACKGROUND & AIMS: Infection is a major problem in advanced liver disease secondary to monocyte dysfunction. Elevated prostaglandin (PG)E(2) is a mediator of monocyte dysfunction in cirrhosis; thus, we examined PGE(2) signalling in outpatients with ascites and in patients hospitalised with acute...
Autores principales: | Maini, Alexander A., Becares, Natalia, China, Louise, Tittanegro, Thais H., Patel, Amit, De Maeyer, Roel P.H., Zakeri, Nekisa, Long, Tu Vinh, Ly, Lucy, Gilroy, Derek W., O’Brien, Alastair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603213/ https://www.ncbi.nlm.nih.gov/pubmed/34825153 http://dx.doi.org/10.1016/j.jhepr.2021.100332 |
Ejemplares similares
-
Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis
por: China, Louise, et al.
Publicado: (2022) -
Evaluating the Role of Antibiotics in Patients Admitted to Hospital With Decompensated Cirrhosis: Lessons From the ATTIRE Trial
por: Kutmutia, Rishen, et al.
Publicado: (2023) -
Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trial
por: Tittanegro, Thais, et al.
Publicado: (2022) -
ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial
por: China, Louise, et al.
Publicado: (2016) -
Immune Regulatory Mediators in Plasma from Patients With Acute Decompensation Are Associated With 3-Month Mortality
por: Becares, Natalia, et al.
Publicado: (2020)